Kolon TissueGene (XKRX:950160) ROE % Adjusted to Book Value : -2.06% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene ROE % Adjusted to Book Value?

Kolon TissueGene's ROE % for the quarter that ended in Sep. 2024 was -15.05%. Kolon TissueGene's PB Ratio for the quarter that ended in Sep. 2024 was 7.29. Kolon TissueGene's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -2.06%.

Kolon TissueGene ROE % Adjusted to Book Value Historical Data

The historical data trend for Kolon TissueGene's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon TissueGene ROE % Adjusted to Book Value Chart

Kolon TissueGene Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.21

-5.85

-8.14

-2.56

-2.93

Kolon TissueGene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.72	-2.29	-1.58	-2.24	-2.06

Competitive Comparison of Kolon TissueGene's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Kolon TissueGene's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kolon TissueGene's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kolon TissueGene's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Kolon TissueGene's ROE % Adjusted to Book Value falls into.

Kolon TissueGene ROE % Adjusted to Book Value Calculation

Kolon TissueGene's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-16.69%	/	5.70
	=	-2.93%

Kolon TissueGene's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.05%	/	7.29
	=	-2.06%

Kolon TissueGene ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Kolon TissueGene's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon TissueGene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850

Website

https://www.tissuegene.com

Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.

Kolon TissueGene Headlines

No Headlines